Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome

Distribution of mast cell subtypes in interstitial cystitis: implications for novel diagnostic and therapeutic strategies?

(2018) Shabana T Malik et al.   JOURNAL OF CLINICAL PATHOLOGY

Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion

(2017) Aram Kim et al.   HISTOPATHOLOGY

Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study

(2017) Xu Wang et al.   PLoS One

Mast Cell - Glia Dialogue in Chronic Pain and Neuropathic Pain: Blood-Brain Barrier Implications

(2016) Stephen D. Skaper   CNS & Neurological Disorders-Drug Targets

A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation

(2016) E. Esposito et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Loss of Bladder Epithelium Induced by Cytolytic Mast Cell Granules

(2016) Hae Woong Choi et al.   IMMUNITY

Effective treatment of polydatin weakens the symptoms of collagen-induced arthritis in mice through its anti-oxidative and anti-inflammatory effects and the activation of MMP-9

(2016) Bo Li et al.   Molecular Medicine Reports

Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential

(2016) Earle R. Nestmann   Food Science & Nutrition

Protective Effect of Palmitoylethanolamide in a Rat Model of Cystitis

(2015) Federica Pessina et al.   JOURNAL OF UROLOGY

Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms

(2014) Andrew Schrepf et al.   PAIN

The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain

(2013) Emilio Giugliano et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

(2013) Stephen D. Skaper et al.   INFLAMMOPHARMACOLOGY

Differences in Mast Cell Infiltration, E-cadherin, and Zonula Occludens-1 Expression Between Patients With Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome

(2012) Hsin-Tzu Liu et al.   UROLOGY

Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)–transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study

(2011) Luigi Cobellis et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Effect of palmitoylethanolamide–polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations

(2010) Ugo Indraccolo et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Beyond neurons: Involvement of urothelial and glial cells in bladder function

(2009) Lori A. Birder et al.   NEUROUROLOGY AND URODYNAMICS

Evaluation of fatty acid amides in the carrageenan-induced paw edema model

(2007) Laura E. Wise et al.   NEUROPHARMACOLOGY